Talkmed Group Ltd (TALK)

Currency in SGD
0.450
-0.005(-1.10%)
Closed·
TALK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
TALK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4500.450
52 wk Range
0.3800.500
Key Statistics
Bid/Ask
0.45 / 0.455
Prev. Close
0.455
Open
0.45
Day's Range
0.45-0.45
52 wk Range
0.38-0.5
Volume
50.2K
Average Volume (3m)
37.59K
1-Year Change
18%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TALK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Talkmed Group Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Talkmed Group Ltd Company Profile

TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, New Zealand, Australia, and the United States. It operates in two segments: Oncology Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematology malignancies and brain cancers, as well as lymphoma and leukaemia. It also provides palliative care services comprising cancer pain management, discharge and home care planning, advance care planning, and end-of-life care planning; and ancillary health services, such as CANSCREEN, a screening program that provides screening for individuals at a risk of getting cancer. In addition, the company offers products and services related to cellular and gene therapy; specialist doctors and clinical staff services; and healthcare management services. Further, it develops novel processing platforms for cell and gene therapy and carrying out research in genetic modification of immune cells; and novel platform viral vector technologies that strive to advance genetic modification of cellular therapy. TalkMed Group Limited was founded in 1997 and is based in Singapore. TalkMed Group Limited is a subsidiary of Citibank Nominees Singapore Pte Ltd.

Compare TALK to Peers and Sector

Metrics to compare
TALK
Peers
Sector
Relationship
P/E Ratio
13.7x2.8x−0.5x
PEG Ratio
0.390.050.00
Price/Book
7.1x1.4x2.6x
Price / LTM Sales
7.7x1.9x3.3x
Upside (Analyst Target)
-1.2%43.5%
Fair Value Upside
Unlock17.6%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.03%
Dividend Yield
8.00%
Industry Median 1.64%
Annualised payout
0.04
Paid unevenly
5-Years Growth
-17.11%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TALK Income Statement

FAQ

What Stock Exchange Does Talkmed Group Ltd Trade On?

Talkmed Group Ltd is listed and trades on the Singapore Stock Exchange stock exchange.

What Is the Stock Symbol for Talkmed Group Ltd?

The stock symbol for Talkmed Group Ltd is "TALK."

What Is the Talkmed Group Ltd Market Cap?

As of today, Talkmed Group Ltd market cap is 598.63M.

What Is Talkmed Group Ltd's Earnings Per Share (TTM)?

The Talkmed Group Ltd EPS (TTM) is 0.03.

When Is the Next Talkmed Group Ltd Earnings Date?

Talkmed Group Ltd will release its next earnings report on 10 Aug 2025.

From a Technical Analysis Perspective, Is TALK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Talkmed Group Ltd Stock Split?

Talkmed Group Ltd has split 1 times.

How Many Employees Does Talkmed Group Ltd Have?

Talkmed Group Ltd has 235 employees.

What is the current trading status of Talkmed Group Ltd (TALK)?

As of 09 Aug 2025, Talkmed Group Ltd (TALK) is trading at a price of 0.45, with a previous close of 0.46. The stock has fluctuated within a day range of 0.45 to 0.45, while its 52-week range spans from 0.38 to 0.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.